A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
Clinical trial NCT00930098 · COMPLETED
Trial details
- NCT number
- NCT00930098
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.